This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Conglomerate 3M’s focus on business transformation — with moves like the localization of decision making and integration of supply chains — enhances its competitive advantage. Also, its recognized product brands and investments in innovation are compelling. Inorganic actions (buyouts and divestments) are added advantages. Acelity, bought in October 2019, is predicted to aid 3M’s medical solutions business. Being one of the largest manufacturers of respiratory masks, the coronavirus outbreak has added to the company’s growth potential.
3M (MMM) Stock Moves -0.18%: What You Should Know
by Zacks Equity Research
3M (MMM) closed at $104.37 in the latest trading session, marking a -0.18% move from the prior day.
Here's Why You Should Give the 3M (MMM) Stock a Shot Now
by Zacks Equity Research
3M (MMM) is poised for growth on the back of improving supply chains, deceleration in cost inflation and strength across key end markets. Handsome rewards to shareholders add to the stock's appeal.
3 Dividend Growth Stocks to Buy and Never Sell
by Ethan Feller
The stocks I share below have a high Zacks Rank and have raised dividends for more than 50 years running
MMM vs. HON: Which Stock Is the Better Value Option?
by Zacks Equity Research
MMM vs. HON: Which Stock Is the Better Value Option?
3M (MMM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
3M (MMM) closed at $102.29 in the latest trading session, marking a +0.04% move from the prior day.
3M's (MMM) Arm Unveils SoluPrep S Sterile Antiseptic Solution
by Zacks Equity Research
3M's (MMM) SoluPrep S Sterile Antiseptic Solution can be used by O.R. nurses, surgeons and infection preventionists who intend to prepare patient skin safely, easily and with confidence before surgery to reduce bacteria on the skin.
3M (MMM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
3M (MMM) closed the most recent trading day at $102.78, moving -0.4% from the previous trading session.
Here's Why it is Time to Add 3M (MMM) to Your Portfolio Now
by Zacks Equity Research
3M (MMM) is poised for growth on the back of improving supply chain and cost management actions. The company's efforts to reward its shareholders handsomely add to its appeal.
3M (MMM) Loses -6.26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
3M (MMM) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
3M (MMM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
3M (MMM) closed the most recent trading day at $101.14, moving +0.14% from the previous trading session.
3M (MMM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
3M (MMM) closed at $104.29 in the latest trading session, marking a -0.02% move from the prior day.
3M (MMM) Flat As Market Sinks: What You Should Know
by Zacks Equity Research
3M (MMM) closed at $102.78 in the latest trading session, marking no change from the prior day.
3M (MMM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
3M (MMM) closed the most recent trading day at $102.78, moving -0.7% from the previous trading session.
3M (MMM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, 3M (MMM) closed at $107.16, marking a +0.07% move from the previous day.
3M (MMM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
3M (MMM) closed at $109.90 in the latest trading session, marking a -0.28% move from the prior day.
3M (MMM) Gets Mired in Headwinds, Stock Down 27% in 6 Months
by Zacks Equity Research
3M (MMM) grapples with softness in disposable respirator demand, inflationary pressure, supply-chain woes and currency headwinds.
3M (MMM) Down 3.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
3M (MMM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Sell Stocks for February 6th
by Zacks Equity Research
CCS, MMM and CADE have been added to the Zacks Rank #5 (Strong Sell) List on February 6, 2023.
BJ's Wholesale Club and 3M have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
BJ's Wholesale Club and 3M have been highlighted as Zacks Bull and Bear of the Day
Bear of the Day: 3M Company (MMM)
by Benjamin Rains
3M fell short of our Q4 fiscal 2022 earnings estimates on January 24 and provided a rough outlook for 2023. The industrial conglomerate's recent setback, which has MMM shares down nearly 45% since May of 2021, is part of a larger downturn over the last five years.
Stock Market News for Jan 25, 2023
by Zacks Equity Research
Wall Street closed mixed on Tuesday as investors digested the latest batch of corporate earnings reports and gauged the state of the economy.
3M (MMM) Misses on Q4 Earnings, Issues Bearish '23 Outlook
by Zacks Equity Research
Adverse foreign currency movements and declining disposable respirator demand hurt 3M's (MMM) Q4 results. Anticipating the persistence of these headwinds, the company provides a bleak outlook for 2023.
Earnings Data Deluge
by Zacks Equity Research
Earnings Data Deluge
Q4 Earnings Season Heats Up: JNJ, MMM, GE & More
by Mark Vickery
Whether pre-market futures are reacting to results or just doing some profit-taking off recent highs is hard to tell -- the Dow is -150 points at this hour, the S&P 500 is -20 and the Nasdaq -85 points currently.
3M (MMM) Q4 Earnings Lag Estimates
by Zacks Equity Research
3M (MMM) delivered earnings and revenue surprises of -2.56% and 0.53%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?